Company Search:
Advanced Search
Sponsored Links
argenx NV Company Snapshot
argenx NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx NV with three other miscellaneous service companies in Europe: GW Pharmaceuticals PLC of the United Kingdom (2016 sales of £10.32 million [US$14.23 million] of which 63% was Commercial), Vernalis Plc of the United Kingdom (£12.03 million [US$16.60 million] of which 67% was Research and development), and Pharming Group NV which is based in the Netherlands (15.87 million Euro [US$19.45 million] of which 100% was Recombinant Proteins).

Sales Analysis. argenx NV reported sales of 14.71 million Euro (US$18.03 million) for the year ending December of 2016. This represents an increase of 114.7% versus 2015, when the company's sales were 6.85 million Euro. Sales at argenx NV have increased during each of the previous five years (and since 2011, sales have increased a total of 1,208%). Sales of License Fees saw an increase that was more than double the company's growth rate: sales were up 314.9% in 2016, from 2.19 million Euro to 9.10 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
argenx NV
  Stock Performance Chart for argenx NV
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 55.90
(Figures in Euro)
1 Week 14.5%   13 Weeks 15.5%  
4 Weeks 157.7%   52 Weeks 240.9%  
argenx NV Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 14,713,000
(Year Ending Jan 2017).
Employees: 56
  Currency: Euro Market Cap: 1,502,101,701
  Fiscal Yr Ends: December Shares Outstanding: 26,871,229
  Share Type: Actions Ordinaires Closely Held Shares: 866,149
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.